JP2021502110A5 - - Google Patents

Download PDF

Info

Publication number
JP2021502110A5
JP2021502110A5 JP2020540688A JP2020540688A JP2021502110A5 JP 2021502110 A5 JP2021502110 A5 JP 2021502110A5 JP 2020540688 A JP2020540688 A JP 2020540688A JP 2020540688 A JP2020540688 A JP 2020540688A JP 2021502110 A5 JP2021502110 A5 JP 2021502110A5
Authority
JP
Japan
Prior art keywords
tcr
lymphocytes
lymphocyte
modified
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020540688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021502110A (ja
JP7260553B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/054664 external-priority patent/WO2019071164A1/en
Publication of JP2021502110A publication Critical patent/JP2021502110A/ja
Publication of JP2021502110A5 publication Critical patent/JP2021502110A5/ja
Application granted granted Critical
Publication of JP7260553B2 publication Critical patent/JP7260553B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020540688A 2017-10-06 2018-10-05 がん特異的抗原に対するtリンパ球のスクリーニング Active JP7260553B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762569215P 2017-10-06 2017-10-06
US62/569,215 2017-10-06
PCT/US2018/054664 WO2019071164A1 (en) 2017-10-06 2018-10-05 SCREENING OF LYMPHOCYTES T FOR ANTIGENS SPECIFIC TO CANCER

Publications (3)

Publication Number Publication Date
JP2021502110A JP2021502110A (ja) 2021-01-28
JP2021502110A5 true JP2021502110A5 (https=) 2021-11-11
JP7260553B2 JP7260553B2 (ja) 2023-04-18

Family

ID=65994277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020540688A Active JP7260553B2 (ja) 2017-10-06 2018-10-05 がん特異的抗原に対するtリンパ球のスクリーニング

Country Status (6)

Country Link
US (1) US11598780B2 (https=)
EP (1) EP3691662A4 (https=)
JP (1) JP7260553B2 (https=)
CN (1) CN111787930B (https=)
AU (2) AU2018346765B2 (https=)
WO (1) WO2019071164A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL297161A (en) * 2020-04-22 2022-12-01 Nutcracker Therapeutics Inc Therapeutic mrna nanoparticles
CN111718409B (zh) * 2020-06-17 2021-03-02 深圳豪石生物科技有限公司 一种t细胞受体及其应用
CN112710849A (zh) * 2020-12-24 2021-04-27 首都医科大学附属北京友谊医院 一种鉴定抗EBV免疫活性的ELISpot试剂盒、制备方法及应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ATE87659T1 (de) 1986-09-02 1993-04-15 Enzon Lab Inc Bindungsmolekuele mit einzelpolypeptidkette.
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US5714330A (en) 1994-04-04 1998-02-03 Lynx Therapeutics, Inc. DNA sequencing by stepwise ligation and cleavage
US5695934A (en) 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US6432360B1 (en) 1997-10-10 2002-08-13 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US6511803B1 (en) 1997-10-10 2003-01-28 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US6485944B1 (en) 1997-10-10 2002-11-26 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
WO2001023610A2 (en) 1999-09-29 2001-04-05 Solexa Ltd. Polynucleotide sequencing
EP1368497A4 (en) 2001-03-12 2007-08-15 California Inst Of Techn METHODS AND APPARATUS FOR ANALYZING ASYNCHRONOUS BASE EXTENSION POLYNUCLEOTIDE SEQUENCES
WO2005003375A2 (en) 2003-01-29 2005-01-13 454 Corporation Methods of amplifying and sequencing nucleic acids
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
WO2006084132A2 (en) 2005-02-01 2006-08-10 Agencourt Bioscience Corp. Reagents, methods, and libraries for bead-based squencing
US7282337B1 (en) 2006-04-14 2007-10-16 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing
US7948015B2 (en) 2006-12-14 2011-05-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US20100297093A1 (en) 2007-09-25 2010-11-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Modified t cell receptors and related materials and methods
US20100035252A1 (en) 2008-08-08 2010-02-11 Ion Torrent Systems Incorporated Methods for sequencing individual nucleic acids under tension
US20100301398A1 (en) 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US8546128B2 (en) 2008-10-22 2013-10-01 Life Technologies Corporation Fluidics system for sequential delivery of reagents
TWI469791B (zh) * 2009-02-18 2015-01-21 Oncotherapy Science Inc Foxm1胜肽以及含此胜肽之疫苗
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
US8574835B2 (en) 2009-05-29 2013-11-05 Life Technologies Corporation Scaffolded nucleic acid polymer particles and methods of making and using
DK2895600T3 (da) * 2012-09-11 2020-04-27 Onco Therapy Science Inc Ube2t-peptider og vacciner, der indeholder disse
WO2014106886A1 (en) * 2013-01-07 2014-07-10 Oncotherapy Science, Inc. Cdca5 peptides and vaccines containing the same
CN106103711A (zh) 2013-11-21 2016-11-09 组库创世纪株式会社 T细胞受体和b细胞受体库分析系统及其在治疗和诊断中的应用
US10202640B2 (en) 2014-05-07 2019-02-12 The Board Of Trustees Of The Leland Stanford Junior University Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
AU2015273501B2 (en) 2014-06-11 2021-01-21 Polybiocept Gmbh Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy
AU2014407539B2 (en) * 2014-10-02 2020-10-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of isolating T cell receptors having antigenic specificity for a cancer-specific mutation
GB201520595D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
RU2021107053A (ru) * 2016-03-16 2021-08-24 Нексиммьюн, Инк. Получение антигенспецифических t-клеток
GB201604492D0 (en) * 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Transfected t-cells and t-cell receptors for use in immunotherapy against cancers

Similar Documents

Publication Publication Date Title
JP6918703B2 (ja) がんを治療するための方法
TWI816702B (zh) 利用熱點識別新抗原之方法及電腦系統
CN111868080B (zh) 利用泛等位基因模型进行的新抗原鉴别
KR102777396B1 (ko) Tcr 및 펩티드
FI3707159T3 (fi) Uusia muokattuja t-solureseptoreita ja niitä käyttävä immuuniterapia
ES2907819T3 (es) Receptor novedoso de linfocitos T
FI3294333T4 (fi) Klaudiini-18.2-spesifiset immunoreseptorit ja t-soluepitoopit
AU2014407539A1 (en) Methods of isolating T cell receptors having antigenic specificity for a cancer-specific mutation
WO2016081947A4 (en) Determinants of cancer response to immunotherapy by pd-1 blockade
EP3602053A1 (en) Methods of isolating neoantigen-specific t cell receptor sequences
US20190247435A1 (en) Neoantigens as targets for immunotherapy
EP3666793A3 (en) Combined t cell receptor gene therapy of cancer against mhc i and mhc ii-restricted epitopes of the tumor antigen ny-eso-1
KR20220108045A (ko) 공유 후보 항원 및 공유 항원-특이적 t 림프구 쌍을 확인 및 검증하기 위한 방법 및 시스템
JP2021502110A5 (https=)
CN116802738A (zh) 为个体化癌症疫苗选择新抗原
CN117886919A (zh) 识别HLA-A2限制性乙肝病毒HBs346-354表位的TCR及其用途
WO2020145901A1 (en) Use of hla-a*11:01-restricted hepatitis b virus (hbv) peptides for identifying hbv-specific cd8+ t cells
AU2023282185B2 (en) Methods of isolating T cell receptors having antigenic specificity for a cancer specific mutation
Hossain et al. Immunogenomics: steps toward personalized medicines
HK40106079A (zh) 治疗癌症的方法
WO2023236954A1 (zh) Pd-1变体及其用途
HK40117197A (zh) 使用热点进行的新抗原鉴别
JP2015133938A (ja) 抗原特異的t細胞受容体の取得方法
WO2021060343A1 (ja) Urlc10由来ペプチドまたはdepdc1由来ペプチドを認識するヒトt細胞が発現するt細胞受容体
JPWO2023006828A5 (https=)